Shanghai Fosun Pharmaceutical (Group) Co Ltd (2196.HK) released a profit for its first quarter that Increased, from the same period last year
The company's earnings came in at RMB870.82 million, or RMB0.33 per share. This compares with RMB764.757 million, or RMB0.29 per share, last year.
The company's revenue for the period rose 6.9% to RMB10.073 billion from RMB9.420 billion last year.
Shanghai Fosun Pharmaceutical (Group) Co Ltd earnings at a glance (GAAP) :
-Earnings: RMB870.82 Mln. vs. RMB764.757 Mln. last year.-EPS: RMB0.33 vs. RMB0.29 last year.-Revenue: RMB10.073 Bln vs. RMB9.420 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.